May 02, 2023 / 08:30PM GMT
Operator
Good afternoon and welcome to the Sarepta Therapeutics First Quarter 2023 Earnings Call. (Operator Instructions) As a reminder, today's program is being recorded.
At this time, I'll turn the call over to Mary Jenkins, Associate Director of Investor Relations. Please go ahead.
Mary Jenkins - Sarepta Therapeutics, Inc. - Senior Manager of IR
Thank you, Shannon, and thank you all for joining today's call. Earlier this afternoon, we released our financial results for the first quarter of 2023. The press release is available on our website at sarepta.com, and our 10-Q was filed with the Securities and Exchange Commission this afternoon.
Joining us on the call today are Doug Ingram, Ian Estepan, Dallan Murray and Dr. Louise Rodino-Klapac. After our formal remarks, we'll open the call for Q&A.
I'd like to note that during this call, we'll be making a number of forward-looking statements. Please take a moment to review our slide on the webcast, which contains our forward-looking statements. These forward-looking statements involve risks
Q1 2023 Sarepta Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot